Participant flow

Combination Bortezomib and Rituximab in Patients With Waldenstrom's Macroglobulinemia (WM) · Source last updated 2020-10-27

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   bortezomib and rituximab Bortezomib: Once weekly for 3 weeks Rituximab: Intravenously once a week for the first and fourth weeks of a cycle

   id

   FG000

   title

   Bortezomib and Rituximab

periods

1. drop Withdraws

   1. reasons

      1. group Id

         FG000

         num Subjects

         6

      type

      Withdrawal by Subject

   2. reasons

      1. group Id

         FG000

         num Subjects

         7

      type

      Adverse Event

   milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         63

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         50

      type

      COMPLETED

   3. achievements

      1. group Id

         FG000

         num Subjects

         13

      type

      NOT COMPLETED

   title

   Overall Study

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice